tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market

Monopar Therapeutics Inc (MNPR) Income Statement

Compare
552 Followers

Monopar Therapeutics Inc Income Statement

Last quarter (Q3 2025), Monopar Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Monopar Therapeutics Inc's net income was $-3.44M. See Monopar Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.16M$ 8.83M$ 10.54M$ 9.13M$ 6.51M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 6.51M
EBITDA
$ -16.16M$ -8.83M$ -10.54M$ -9.13M$ 0.00
Operating Income
$ -16.16M$ -8.83M$ -10.54M$ -9.13M$ -6.51M
Other Income/Expenses
$ 575.30K$ 429.04K$ 21.24K$ 24.02K$ 204.30K
Pretax Income
$ -15.59M$ -8.40M$ -10.52M$ -9.10M$ -6.30M
Net Income
$ -15.59M$ -8.40M$ -10.52M$ -9.10M$ -6.30M
Per Share Metrics
Basic EPS
$ -1.36$ -0.58$ -0.83$ -0.73$ -0.58
Diluted EPS
$ -1.36$ -0.58$ -0.83$ -0.73$ -0.58
Weighted Average Shares Outstanding
11.44M 14.51M 12.72M 12.47M 10.96M
Weighted Average Shares Outstanding (Diluted)
11.48M 14.51M 12.72M 12.47M 10.96M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History